Nutrien Ltd.

TSX:NTR Stock Report

Market Cap: CA$44.0b

Nutrien Past Earnings Performance

Past criteria checks 4/6

Nutrien's earnings have been declining at an average annual rate of -19.2%, while the Chemicals industry saw earnings growing at 26.5% annually. Revenues have been declining at an average rate of 1.4% per year. Nutrien's return on equity is 9.6%, and it has net margins of 8.9%.

Key information

-19.25%

Earnings growth rate

-16.39%

EPS growth rate

Chemicals Industry Growth4.55%
Revenue growth rate-1.38%
Return on equity9.59%
Net Margin8.88%
Next Earnings Update06 Aug 2026

Recent past performance updates

Recent updates

Narrative Update Jun 05

NTR: Tighter Fertilizer Markets Will Support Higher Future Earnings Multiple

The updated fair value estimate for Nutrien has moved to CA$109.12 from CA$105.25 as analysts factor in recent mixed price target revisions and a higher assumed future P/E multiple, even as revenue growth and profit margin assumptions are reset lower. Analyst Commentary Recent research on Nutrien reflects a mix of optimism and caution, with several firms adjusting ratings and targets in both directions.
Narrative Update May 20

NTR: Tighter Fertilizer Markets And DOJ Probe Will Guide Future Returns

Analysts have trimmed the fair value estimate for Nutrien to CA$92.08 from CA$95.15, reflecting slightly lower revenue and margin assumptions, even as recent research points to mixed price target changes across the Street. Analyst Commentary Recent Street research presents a mixed picture, with some firms lifting price targets and ratings while others trim expectations or shift to a more cautious stance.
Narrative Update May 03

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Future Returns

The updated analyst price target for Nutrien reflects a small decrease of about CA$0.26. Analysts are balancing slightly softer implied revenue growth and a marginally higher discount rate against firmer profit margin assumptions and a modestly lower future P/E multiple.
Narrative Update Apr 19

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has risen by CA$4.18. Analysts attribute this change to updated assumptions for slightly stronger revenue growth, higher profit margins, and a lower future P/E multiple, reflecting the recent wave of higher sector targets and tighter global fertilizer markets.
Narrative Update Apr 04

NTR: Tighter Fertilizer Markets And DOJ Probe Will Pressure Future Returns

Analysts have nudged the fair value estimate for Nutrien higher to CA$95.41. This reflects a modestly lower discount rate, slightly firmer long term margin assumptions, and updated sector P/E comparisons that incorporate a wave of recent price target increases tied to tighter fertilizer markets and higher commodity pricing expectations.
Narrative Update Mar 21

NTR: Higher Fertilizer Pricing And DOJ Probe Will Shape Share Performance

Analysts have lifted the average Nutrien price target by roughly CA$31 to around CA$95, citing stronger fertilizer pricing, higher expected profit margins and support for elevated sector valuation multiples, despite more cautious views on volume growth. Analyst Commentary Recent research on Nutrien largely centers on fertilizer pricing, geopolitical risks and the earnings impact of tighter nitrogen and potash markets.
Narrative Update Mar 07

NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation. Analyst Commentary Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation.
Narrative Update Feb 21

NTR: Firmer Nutrient Pricing And Potash Supply Risks Will Shape Balanced Returns

Our updated fair value estimate for Nutrien edges higher to CA$96.56 from CA$91.99, reflecting a series of analyst price target increases tied to refreshed models after recent results, stronger assumed profit margins, and expectations that nutrient pricing holds firmer for longer, even as some remain cautious about future potash supply. Analyst Commentary Street research on Nutrien has been active, with several firms revisiting their models and adjusting price targets around recent and upcoming quarterly results.
Narrative Update Feb 07

NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple. Analyst Commentary Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds.
Narrative Update Jan 23

NTR: Higher Fertilizer Pricing And Buybacks Will Support Future Upside

Our analyst price target for Nutrien edges slightly lower to about $112.49 from $113.03, as analysts weigh mixed sector commentary on fertilizer and agriculture markets against recent target adjustments and an updated future P/E assumption of roughly 20.2x. Analyst Commentary Recent Street research on Nutrien reflects mixed sector views but a generally supportive tone on the company, with several bullish analysts adjusting targets and ratings while acknowledging a more cautious backdrop for fertilizers and agriculture.
Narrative Update Jan 09

NTR: Fertilizer Cycle Concerns Will Pressure Shares Despite Recent Buybacks

Narrative Update Analysts have nudged their consolidated price target for Nutrien down by about $2 to $64. This reflects updated views that factor in more cautious fertilizer and agriculture setups, modestly lower assumed revenue growth, a slightly higher profit margin profile, and a reduced future P/E multiple in their models.
Narrative Update Dec 21

NTR Is Expected To Benefit From Potential Upside In Fertilizer Pricing

Analysts have modestly reduced their price target on Nutrien to approximately $113 from about $97, citing a tougher near term backdrop for farmers, slightly lower growth and margin expectations, and a more balanced risk reward profile after the stock's strong run. Analyst Commentary Recent Street research reflects a mixed but generally constructive stance on Nutrien, with several firms trimming price targets modestly while maintaining positive ratings.
Narrative Update Dec 07

NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution. Analyst Commentary Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.
Narrative Update Nov 23

NTR: Portfolio Streamlining And Asset Sales Will Drive Sector Outperformance Ahead

Nutrien's analyst price target has been modestly reduced by $0.21 to $88.43. Analysts cite ongoing sector headwinds, including weaker crop prices, portfolio adjustments, and a more balanced risk-reward outlook, despite solid recent performance.
Narrative Update Nov 07

NTR: Portfolio Streamlining and Supply Tightness Will Shape Upside Amid Sector Scrutiny

Nutrien’s average analyst price target has edged slightly lower in recent weeks, as analysts weigh a modestly improving profit margin and fair value estimate against easing revenue growth and persistent caution over the agricultural cycle. Analyst Commentary Recent analyst activity around Nutrien highlights both opportunities and challenges for the company as it navigates ongoing market volatility and shifting sector dynamics.
Narrative Update Oct 24

Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty

Nutrien's analyst price targets have recently edged lower by $1 to $2 per share, as analysts cite cautious earnings expectations, a more balanced risk-reward profile, and the impact of portfolio adjustments on future performance. Analyst Commentary Recent Street research highlights a divided outlook among analysts covering Nutrien, reflecting both positive and cautionary perspectives as the company navigates its next phase of growth and portfolio transformation.
Narrative Update Oct 09

Global Food Demand And Precision Ag Will Secure Fertilizer Success

Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions. Analyst Commentary Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity.
Analysis Article Sep 08

With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For

Nutrien Ltd.'s ( TSE:NTR ) price-to-earnings (or "P/E") ratio of 20.1x might make it look like a sell right now...
Analysis Article Aug 08

Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Shareholders might have noticed that Nutrien Ltd. ( TSE:NTR ) filed its second-quarter result this time last week. The...
Analysis Article Jul 16

Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
Analysis Article Jul 03

A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Nutrien fair value estimate is CA$98.09 Current share price of...
User avatar
New Narrative Feb 09

Accelerated Efficiency And Expanded Potash And Nitrogen Output Will Strengthen Future Operations

Accelerated operational efficiency and strategic sales expansion may enhance margins and boost revenue without significant new capital expenditure.

Revenue & Expenses Breakdown

How Nutrien makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSX:NTR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2626,8772,3874,2150
31 Dec 2525,9492,2674,0870
30 Sep 2525,6711,8094,0800
30 Jun 2525,0211,3634,0900
31 Mar 2524,7395274,1180
31 Dec 2425,0166744,1210
30 Sep 2425,5567334,2070
30 Jun 2425,8397904,2220
31 Mar 2427,3258454,1180
31 Dec 2328,0821,2584,0940
30 Sep 2329,9672,1983,9490
30 Jun 2332,5833,7003,9590
31 Mar 2335,4666,8533,9920
31 Dec 2237,0127,6604,0500
30 Sep 2236,7927,7494,1800
30 Jun 2234,6126,8894,1010
31 Mar 2229,8684,4044,0150
31 Dec 2126,8613,1533,8260
30 Sep 2123,6422,2683,6630
30 Jun 2121,8619643,5520
31 Mar 2120,5146213,4090
31 Dec 2020,0534593,3240
30 Sep 2019,534953,2130
30 Jun 2019,4708233,0840
31 Mar 2019,7549163,0520
31 Dec 1919,3169923,0280
30 Sep 1919,6711,3362,8890
30 Jun 1919,4491282,9290
31 Mar 1918,862112,9300
31 Dec 1818,772-312,8910
30 Sep 1816,051-4472,2980
30 Jun 1813,3766361,6310
31 Mar 186,489478290
31 Dec 174,0101542330
30 Sep 173,9731962180
30 Jun 173,8932612210
31 Mar 173,8242302330
31 Dec 163,9211992310
30 Sep 164,2394782530
30 Jun 164,6586792460
31 Mar 165,3309752510
31 Dec 155,7911,1152580
30 Sep 156,3031,4762580
30 Jun 156,4021,5112550

Quality Earnings: NTR has high quality earnings.

Growing Profit Margin: NTR's current net profit margins (8.9%) are higher than last year (2.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NTR's earnings have declined by 19.2% per year over the past 5 years.

Accelerating Growth: NTR's earnings growth over the past year (352.9%) exceeds its 5-year average (-19.2% per year).

Earnings vs Industry: NTR earnings growth over the past year (352.9%) exceeded the Chemicals industry 0.6%.


Return on Equity

High ROE: NTR's Return on Equity (9.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 03:33
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nutrien Ltd. is covered by 52 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harriet LiAccountability Research Corporation
Keith CarpenterATB Cormark
Benjamin TheurerBarclays